CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia
AM Alayoubi, ZY Khawaji, MA Mohammed… - Annals of …, 2024 - Springer
Gene therapy represents a significant potential to revolutionize the field of hematology with
applications in correcting genetic mutations, generating cell lines and animal models, and …
applications in correcting genetic mutations, generating cell lines and animal models, and …
CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia
AM Alayoubi, ZY Khawaji, MA Mohammed… - Annals of … - pubmed.ncbi.nlm.nih.gov
Gene therapy represents a significant potential to revolutionize the field of hematology with
applications in correcting genetic mutations, generating cell lines and animal models, and …
applications in correcting genetic mutations, generating cell lines and animal models, and …
CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia.
AM Alayoubi, ZY Khawaji, MA Mohammed… - Annals of …, 2023 - europepmc.org
Gene therapy represents a significant potential to revolutionize the field of hematology with
applications in correcting genetic mutations, generating cell lines and animal models, and …
applications in correcting genetic mutations, generating cell lines and animal models, and …